Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2007
12/27/2007WO2007149119A1 Water stabilized aerosol formulation system and method of making
12/27/2007WO2007149096A1 Stabilizing alkylglycoside compositions and methods thereof
12/27/2007WO2007149032A1 Antibody molecules for human il-17
12/27/2007WO2007149012A1 Live tularemic vaccine nik-sp.f. tularensis
12/27/2007WO2007149010A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
12/27/2007WO2007148924A1 Use of colloidal gold as an adjuvant
12/27/2007WO2007148417A1 Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
12/27/2007WO2007148229A2 Immunogenic multivalent adhesin particles
12/27/2007WO2007148048A1 Compositions comprising chitin microparticles and their medical uses
12/27/2007WO2007147823A1 Method for the preparation of specific antibodies against saccharidic antigens
12/27/2007WO2007147806A1 Allorestricted peptide-specific t cells
12/27/2007WO2007147623A2 A novel target in the treatment of cytokine release syndrome
12/27/2007WO2007147529A2 Recombinant viral vaccine
12/27/2007WO2007147528A1 Process for producing poxviruses and poxvirus compositions
12/27/2007WO2007147255A1 Synthetic monodisperse hemozoin crystals preparation and uses thereof
12/27/2007WO2007124698A3 Methods for the treatment of flavivirus infection, molecules and uses thereof
12/27/2007WO2007124479A3 Avian influenza viruses, vaccines, compositions, formulations, and methods
12/27/2007WO2007109583A3 Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
12/27/2007WO2007103792A3 Methods and compositions for diagnosis and immunotherapy of pollen allergy
12/27/2007WO2007101262A3 Attenuated francisella bacteria
12/27/2007WO2007085969A3 Influenza vaccines containing hemagglutinin and matrix proteins
12/27/2007WO2007085962A3 Novel glycolipid adjuvant compositions
12/27/2007WO2007084599A3 Methods of increasing lymphatic function
12/27/2007WO2007076520A3 Multivalent pcv2 immunogenic compositions and methods of producing such compositions
12/27/2007WO2007060546A3 Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis
12/27/2007WO2007027860A3 Adenoviral vector-based malaria vaccines
12/27/2007WO2007002139A8 Neuroprotection of retinal ganglion cells
12/27/2007WO2006052668A3 Induction of antigen specific immunologic tolerance
12/27/2007WO2005044200A3 Methods and compositions for treating mcp-1 related pathologies
12/27/2007WO2005019267A8 Tie1-binding ligands
12/27/2007WO2003066824A3 Albumin-fused kunitz domain peptides
12/27/2007US20070299390 Needleless syringe using supersonic gas flow for particle delivery
12/27/2007US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders
12/27/2007US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders
12/27/2007US20070298461 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
12/27/2007US20070298116 Amorphous, spray-dried powders having a reduced moisture content and a high long term stability
12/27/2007US20070298093 Synergistic Liposomal Adjuvants
12/27/2007US20070298056 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
12/27/2007US20070298055 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders
12/27/2007US20070298054 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation
12/27/2007US20070298053 Cattle reproductive disease vaccines
12/27/2007US20070298052 Drying Process for Presserving an Active Agent as a Higly Viscous Liquid
12/27/2007US20070298051 Adjuvants Of Immune Response
12/27/2007US20070298048 Non-viral gene delivery system
12/27/2007US20070298047 Recombinant antigens for diagnosis and prevention of murine typhus
12/27/2007US20070298046 Identifying T-cells in a sample that become activated in the presence of an amino acid sequence of a peptide with the same function as a CD8 T cell epitope of a vaccinia or variola virus; diagnosing vaccinia or variola virus infection by determining if the T-cells are activated by the peptide
12/27/2007US20070298045 Method and vaccine for non-genetically engineered atavism growth enhancement
12/27/2007US20070298044 Enhancing the efficacy of immunotherapies by supplementing with complement
12/27/2007US20070298043 Novel Antibacterial Agents and Methods of Identifying and Utilizing Same
12/27/2007US20070298042 Comprises two heavy chains and two light chains, each chain comprising a variable region and a constant region; vaccines for prevention and diagnosis of viral diseases
12/27/2007US20070298041 Ligands That Enhance Endogenous Compounds
12/27/2007US20070298040 Methods of treating seronegative arthropathy with anti-TNF antibodies
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298038 Compositions and methods for treating kidney disease
12/27/2007US20070298037 administering antagonist to ztnfr14 comprising antibodies, antibody fragments, proteins or polypeptides, for the treatment of psoriasis, inflammatory bowel disease or multiple sclerosis in mammals
12/27/2007US20070298036 PRO71238 Polypeptides
12/27/2007US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection
12/27/2007US20070298034 Sulfotyrosine specific antibodies and uses therefor
12/27/2007US20070298033 Human Anti-Idiotypic Antibody Fragments that Mimic Her-2/Neu
12/27/2007US20070298032 Proteins Involved In Quorum Sensing
12/27/2007US20070298031 Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin
12/27/2007US20070298030 Copper lowering treatment of inflammatory and fibrotic diseases
12/27/2007US20070298029 Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors
12/27/2007US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
12/27/2007US20070298027 Novel Target for Antiderpressant Therapy
12/27/2007US20070298026 Methods for Identifying Treatment and Inducing Infertility Using Smc1-Beta
12/27/2007US20070298011 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/27/2007US20070298009 protect neural cells from degeneration and/or death in response to traumatic brain injury or autoimmune disorders of the brain, such as multiple sclerosis and in reducing seizures; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease
12/27/2007US20070297983 Inhibition of breast carcinoma stem cell growth and metastasis
12/27/2007US20070297977 TNF-gamma-beta polypeptides whose antagonists are used as a therapeutic to treat cachexia, septic shock, cerebral malaria, inflammation, arthritis and graft-rejection
12/27/2007CA2826738A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007CA2714867A1 Non-aggregated pharmaceutically active peptide
12/27/2007CA2659124A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
12/27/2007CA2656918A1 Anti-c35 antibodies for treating cancer
12/27/2007CA2656259A1 Process for producing poxviruses and poxvirus compositions
12/27/2007CA2656168A1 Methods and compositions for targeting hepsin
12/27/2007CA2655986A1 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
12/27/2007CA2655976A1 Antibody molecules for human il-17
12/27/2007CA2655934A1 Soluble stabilized trimeric hiv env proteins and uses thereof
12/27/2007CA2655929A1 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins
12/27/2007CA2655289A1 Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
12/27/2007CA2655138A1 Compositions comprising chitin microparticles and their medical uses
12/27/2007CA2654408A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
12/27/2007CA2654178A1 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin
12/27/2007CA2652924A1 Methods of modulating il-22 and il-17
12/27/2007CA2652457A1 Use of ppd for the adjuvantation of a nucleic acid vaccine
12/27/2007CA2637036A1 Water stabilized aerosol formulation system and method of making
12/26/2007EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors
12/26/2007EP1870468A2 LPS with reduced toxicity from genetically modified gram negative bacteria
12/26/2007EP1870467A1 Polypeptide hormone Phosphatonin
12/26/2007EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer
12/26/2007EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies
12/26/2007EP1870459A1 Methods for producing polypeptides by regulating polypeptide association
12/26/2007EP1870458A1 sc(Fv)2 STRUCTURAL ISOMERS
12/26/2007EP1870422A1 Means for the treatment of diseases characterized by an excessive immune reaction
12/26/2007EP1870418A1 Allorestricted peptide-specific T cells
12/26/2007EP1870109A1 Improved combined vaccine against mycoplasma hyopneumoniae and porcine viruses
12/26/2007EP1870091A1 Liposome composition for induction of immunity
12/26/2007EP1869470A1 Use of protein 2e9 for in vitro diagnosis of mycoplasma pneumoniae infections
12/26/2007EP1869226A2 Viral nucleoprotein detection using an ion channel switch biosensor
1 ... 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 ... 1823